ICON Plc

@ICONplc

Global provider of Outsourced Clinical Research

Dublin
iconplc.com
Vrijeme pridruživanja: veljača 2009.
2.661 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @ICONplc

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ICONplc

  1. Prikvačeni tweet
    9. svi 2019.

    The new ICON Platform enables patients to access new and ongoing studies and a pre-qualification questionnaire helps to determine if the study is a right fit for them. Read the full release

    13 proslijeđenih tweetova 43 korisnika označavaju da im se sviđa
    Poništi
  2. prije 6 sati

    Read our Q&A on from Chris Learn & Martin Lachs regarding their success in the field. Read the full article here

    1 proslijeđeni tweet
    Poništi
  3. prije 22 sata

    ICON & are nominated in the Best , Best Central & Best Network Award categories at the Industry Excellence Awards 2020! Don't forget to vote for us before 2/21

    1 korisnik označava da mu se sviđa
    Poništi
  4. 4. velj

    ICON continues its research in through various & . Find out more

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Poništi
  5. 4. velj

    Hybrid CSS-MCR studies can be advantageous in generating to answer questions efficiently and effectively. Read more in our blog post

    ICON Blog Post January 2020
    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  6. 3. velj

    Read our recent article exploring the evolving role of in the arena & the importance prioritising the integration & interrelation of technology in 2020

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  7. 3. velj

    ICON's Martin Lachs & Brandon Fletcher provide insights & expert opinions on (ACT) : The Long Road. Read the full article

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  8. 3. velj

    Learn how disease natural history information can be used as a historical control in in our recent Pharmafile article .

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  9. 3. velj

    Conducting a for your ? Learn how ICON experts can help at 's conference, booth #7

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  10. 3. velj

    Our Standardisation specialists have the experience and expertise for a smooth & efficient end-to-end delivery. Download our to explore how ICON helped a client successfully convert CDISC data across multiple studies

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  11. 2. velj

    View ICON's award-winning 2019 research poster to explore the 'Cost-Effectiveness of Based Drug Regimens for the Initial Treatment of Patients with Non-Squamous Non-Small Cell '

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  12. 1. velj

    ⅔ of survey respondents said has the potential to increase pharma productivity by 26% or more. Learn more

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  13. proslijedio/la je Tweet
    31. sij

    Improving Patient Adherence & Outcome Measurement with Design Join us for a first-hand experience of gamified technology to gain insights from the Sea Hero Quest video game project to help in 's disease research.

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    31. sij

    Thanks for sharing this informative piece on digital technology like “BIG DATA, AI and Organ on a chip” are disrupting the way we do R&D and trials. Page 20 onwards gives you a snap shot on how R&D will be implemented in the near future!

    Emerging digital tech, such as , , and , offer an opportunity to improve R&D productivity. Read how here
    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Poništi
  15. 30. sij

    How will revolutionise designs? Read the whitepaper

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  16. 30. sij

    Outsourcing the (PV) activities to a service provider introduces , resource optimisation & flexibility into your global PV activity. Read more in our whitepaper

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  17. 30. sij

    How can using historical controls help to expedite & improve to new therapies? Learn about this in our recent article

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  18. 29. sij

    and were viewed as the with the most potential to improve clinical R&D productivity, according to an ICON . Explore how to best implement it here

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  19. 29. sij

    Visit us at , booth 212 to discover how ’s digital solutions for education & automation drive efficiency in

    1 reply 2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
    Poništi
  20. 28. sij

    ICON's Aidan McGovern & Vanita Tongbram win award for their '19 poster showcasing a 'Targeted of the of associated with '. View online now/download a PDF copy @

    #ISPOREurope 2019
    ISPOR Europe 2019
    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  21. 28. sij

    From the moment a patient is identified for a , the can make it safer & easier for them to participate. Learn more

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi

@ICONplc još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·